Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 1
2(40.0%)
N/A
2(40.0%)
Phase 2
1(20.0%)
5Total
Phase 1(2)
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07220694Not ApplicableRecruiting

Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance

Role: collaborator

NCT06080841Not ApplicableRecruiting

Curcumin Supplementation in Cervical Cancer

Role: collaborator

NCT00094445Phase 2Completed

Trial of Curcumin in Advanced Pancreatic Cancer

Role: collaborator

NCT02176889Phase 1Completed

A Parallel Study Evaluating the Safety of Lactospore® in Healthy Individuals

Role: collaborator

NCT01608139Phase 1Withdrawn

Study of Curcumin, Vorinostat, and Sorafenib

Role: collaborator

All 5 trials loaded